Gene · 839
NIH grants1,719
NIH grants whose papers are about the gene, through NIH's grant-paper links.
121 to 140 of 1,719
Download this page as JSON| Grant | Title | CASP6 papers | Newest fiscal year |
|---|---|---|---|
| R01ES032643 | Humanized mouse models for arsenic toxicology | 1 | 2025 |
| R01EY012601 | Hematopoietic cell mobilization from distinct bone marrow compartments following retinal injury | 1 | 2025 |
| R01EY016077 | Dyslipidemia and Diabetic Retinopathy | 1 | 2025 |
| R01EY027824 | Regulation of blood-retina barrier by placental growth factor | 1 | 2025 |
| R01EY028158 | Mechanisms and consequences of impaired glutathione homeostasis in the aging lens | 1 | 2025 |
| R01GM122763 | Structure and Functionof Nanog in Stem Cell Pluripotency | 1 | 2025 |
| R01GM122923 | Characterizing the Regulation of Ferroptosis | 1 | 2025 |
| R01GM130091 | Quantitative Characterization of Glycopeptide Isomers | 1 | 2025 |
| R01GM132640 | Investigating the Proline Cycle as a Potential Cancer Therapy Target | 1 | 2025 |
| R01HL076179 | Improvement of Organ Function after Severe Hypovolemia | 1 | 2025 |
| R01HL158691 | Obesity-induced dysfunction of human MSC in peripheral microvascular repair | 1 | 2025 |
| R01HL166004 | Elucidating the role of the gut reservoir and inflammation in driving cardiovascular disease among persons living with HIV | 1 | 2025 |
| R01LM012011 | Interpretable deep learning models for translational medicine Renewal | 1 | 2025 |
| R01MH127979 | Targeting the HIV-1 Reservoir in Myeloid Cells | 1 | 2025 |
| R01MH128021 | Targeting HIV Myeloid Reservoirs in the CNS by IAP and TREM1 Inhibition | 1 | 2025 |
| R01MH128158 | Phase II study to evaluate the efficacy and safety of baricitinib for reduction of HIV in the central nervous system | 1 | 2025 |
| R01NS027699 | Molecular Studies of Spinocerebellar Ataxia Type 1 | 1 | 2025 |
| R01NS049488 | Characterization of sexual dimorphism in the brain | 1 | 2025 |
| R01NS053538 | Astrocyte control of neural circuits and behavior | 1 | 2025 |
| R01NS088197 | Omega 3 Fatty Acids, Acute Neuroprotection Via Mitochondria | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/839/grants?page=7